Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221134385. doi: 10.1177/15330338221134385.
MicroRNA-378a (miR-378a), including miR-378a-3p and miR-378a-5p, are encoded in gene. miR-378a is essential for tumorigenesis and is an independent prognostic biomarker for various malignant tumors. Aberrant expression of miR-378a affects several physiological and pathological processes, including proliferation, apoptosis, tumorigenesis, cancer invasion, metastasis, and therapeutic resistance. Interestingly, miR-378a has a dual functional role in either promoting or inhibiting tumorigenesis, independent of the cancer type. In this review, we comprehensively summarized the role and regulatory mechanisms of miR-378a in cancer development, hoping to provide a direction for its potential use in cancer therapy.
微小 RNA-378a(miR-378a),包括 miR-378a-3p 和 miR-378a-5p,编码于 基因。miR-378a 对肿瘤发生至关重要,是各种恶性肿瘤的独立预后生物标志物。miR-378a 的异常表达影响包括增殖、凋亡、肿瘤发生、癌症侵袭、转移和治疗抵抗在内的几种生理和病理过程。有趣的是,miR-378a 在促进或抑制肿瘤发生方面具有双重功能作用,而与癌症类型无关。在这篇综述中,我们全面总结了 miR-378a 在癌症发展中的作用和调控机制,希望为其在癌症治疗中的潜在应用提供一个方向。